Latest News and Press Releases

Chiesi Group’s leadership recognized by Administration officials at COP27 CARY, N.C., Nov. 10, 2022 (GLOBE NEWSWIRE) -- Chiesi Group, the international research-focused biopharmaceutical group, was...

Chiesi USA recognized for its dedication to ensuring that employee voices are heard and valued CARY, N.C., Oct. 17, 2022 (GLOBE NEWSWIRE) -- Chiesi USA, Inc. (key-A-zee), the U.S. affiliate of...

CARY, N.C., Oct. 03, 2022 (GLOBE NEWSWIRE) -- Chiesi USA (key-A-zee), a Cary-based specialty pharmaceutical company, felt like part of the team as the company concluded its presenting strikeout...

The Group has increased its B Impact score by 16.3 points, with 103.8 out of 200 compared to its first certification in 2019The recertification process by B Lab identifies further focus for action and...

Chiesi USA sponsored the innovative ASHP Foundation Pharmacy Leadership Scholars program, awarding $50,000 in grants to five early-stage pharmacist researchers CARY, N.C., Sept. 06, 2022 ...

Chiesi Group signed the HHS Health Care Sector Climate Pledge to achieve even greater progress on climate resilienceThe White House cited Chiesi’s leadership in exceeding the pledge by tackling...

Chiesi’s Annual and Sustainability Report 2021 is released today;Progress toward business, environmental and social targets is strong;Company is joining forces with all stakeholders to advance...

The CAMEO registry, an ongoing study to provide real-world data on KENGREAL® (cangrelor), has published interim results in the Journal of the American Heart Association.This analysis from CAMEO is the...

Chiesi Group turnover of €2.42bn supported by strong international growth of 8.6%Growth across global markets, with U.S. up more than 10% and China up 22%Continued focus on innovation: Chiesi invests...

CARY, N.C., March 16, 2022 (GLOBE NEWSWIRE) -- Chiesi USA, Inc. (key-A-zee), a Cary-based specialty pharmaceutical company, contributed more than $815,000 in 2021 through its Chiesi in the Community...